Who
David A. Dodd
President, CEO
Company insider
Files Form 4 as: President, CEO, GeoVax Labs; Chief Executive Officer, Medizone International; President and CEO, Serologicals.
In numbers
- Trades disclosed
- 48
- Buys
- 11
- Sells
- 0
- Bought
- $629K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 15 Mar 2006
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,300 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,300 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —185,500 at $0.00 | filing |
| 1 Apr 2025filed 1 Apr 2025 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $11K10,000 at $1.08 | filing |
| 12 Aug 2024filed 14 Aug 2024 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 9 Aug 2024filed 12 Aug 2024 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $16K8,000 at $1.95 | filing |
| 22 Feb 2024filed 22 Feb 2024 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $19K8,209 at $2.27 | filing |
| 21 Feb 2024filed 22 Feb 2024 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $1,118520 at $2.15 | filing |
| 25 Aug 2023filed 28 Aug 2023 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $20K35,087 at $0.57 | filing |
| 1 Aug 2023filed 14 Aug 2023 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 24 Apr 2023filed 25 Apr 2023 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $20K32,000 at $0.64 | filing |
| 7 Dec 2021filed 8 Dec 2021 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —103,000 at $0.00 | filing |
| 11 Aug 2021filed 11 Aug 2021 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —273,000 at $0.00 | filing |
| 29 Sep 2020filed 29 Sep 2020 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code P | —81,870 at $0.00 | filing |
| 29 Sep 2020filed 29 Sep 2020 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $409K81,870 at $5.00 | filing |
| 17 Dec 2018filed 19 Dec 2018 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —785,000 at $0.00 | filing |
| 1 Sep 2018filed 5 Sep 2018 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000,000 at $0.00 | filing |
| 2 Jan 2018filed 4 Jan 2018 | Medizone International | SEC FORM 4 Code J | —1,000,000 at $0.00 | filing |
| 20 Dec 2017filed 22 Dec 2017 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —270,000 at $0.00 | filing |
| 24 Oct 2017filed 25 Oct 2017 | Medizone International | SEC FORM 4 Code A | $100K2,000,000 at $0.05 | filing |
News
Lisata Therapeutics (NASDAQ:LSTA) & GeoVax Labs (NASDAQ:GOVX) Head to Head ContrastGOVX · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name David A. Dodd; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.